CAS RN: 484-20-8 | Product Number: B2840
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Appearance||White to Light yellow powder to crystal|
|Purity(GC)||min. 98.0 %|
|Melting point||189.0 to 193.0 °C|
|Melting Point||191 °C|
|Maximum Absorption Wavelength||480(MeOH) nm|
|Solubility in water||Practically insoluble|
|Solubility (soluble in)||Ether|
|Solubility (slightly sol. in)||Benzene,Chloroform,Alcohol|
|Hazard Statements||H317 : May cause an allergic skin reaction.
H350 : May cause cancer.
|Precautionary Statements||P261 : Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention.
- The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD (a review)
- 5-Methoxypsoralen: a review of its effects in psoriasis and vitiligo (a review)
- Photoreactivity of Furocoumarins and DNA in PUVA Therapy: Formation of Psoralen－Thymine Adducts
- Mechanism-Based Inactivation of Cytochrome P450 2B1 by 8-Methoxypsoralen and Several Other Furanocoumarins
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.